UBS analyst Chris Snyder upgrades Trane Technologies (NYSE:TT) from Neutral to Buy and raises the price target from $168 to $200.
CORRECTION: Tivic Health Systems Q2 Sales $528.00K Beat $460.00K Estimate
Tivic Health Systems (NASDAQ:TIVC) reported quarterly sales of $528.00 thousand which beat the analyst consensus estimate of $460.00 thousand by 14.78 percent.